Revacept
This is the name of our therapeutic agent for the prevention of stroke and heart attack. Its principle effectiveness has already been proven in patients. It is a soluble protein which, when blood vessels are damaged, covers the damaged areas. Revacept is designed to protect the vessel walls so that vascular occlusion does not occur.
Revacept has been shown to be well tolerated and effective in a Phase II study in carotid artery damage and heart damage. Further studies are in preparation and modified Revacept products are in pre-clinical research.